Back to search

United Kingdom· GB-APID-4748711000001102

Kineret 100mg/0.67ml solution for injection pre-filled syringes

A anakinra product containing anakinra, registered in United Kingdom by Swedish Orphan Biovitrum Ltd. The same ATC class is registered in 13 of our 19 countries.

ATC L04AC03

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedKineret 100mg/0.67ml solution for inj…ATCL04AC03REGISTER NO.GB-APID-4748711000001…PACKS LISTED5CHECKEDSeptember 13, 2026

Where it is registered

Anakinra is registered in 13 of 19 countries.

Countries holding a registration under ATC L04AC03 (anakinra), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 8 of them publish a price we can compare per daily dose

Anakinra · ATC L04AC03

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Anakinra
Manufacturer
Swedish Orphan Biovitrum Ltd
Country
United Kingdom (GB)
ATC code
L04AC03
ATC class
Anakinra
Defined daily dose
0.1 g, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 5

  • gtin
    7350046070042
  • gtin
    07350031442090
  • gtin
    7350031442090
  • gtin
    7350031443288
  • gtin
    7350031443332

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

375 interactions on record for anakinra.

Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Anakinra · interactions on record

375 records

  • 31 severe
  • 337 moderate
  • 7 minor

Most severe, free to view

  • CladribineL01BB04severe
  • PrednisoloneA07EA01moderate
  • HydrocortisoneA07EA02moderate
  • PrednisoneA07EA03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7634fcf8-6791-4565-8558-1771b4e66f5e
GET /v1/drugs/7634fcf8-6791-4565-8558-1771b4e66f5e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "4748711000001102",
  "desc": "Kineret 100mg/0.67ml solution for injection pre-filled syringes (Swedish Orphan Biovitrum Ltd)",
  "form": "Solution for injection",
  "vpid": "4751711000001105",
  "source": "dmd",
  "vtm_id": "774605000",
  "strength": "150 mg",
  "substance": "Anakinra",
  "ingredient": "Anakinra",
  "supplier_code": "4232111000001108"
}

See everything about anakinra.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.